Please enable JavaScript to continue using this application.

Compare $KYMR vs $TWST | Chartloom

Compare

$KYMR vs $TWST

Kymera Therapeutics Inc · Twist Bioscience Corp

KYMR

Kymera Therapeutics Inc

TWST

Twist Bioscience Corp

Compare $KYMR vs $TWST

Comparing Kymera Therapeutics Inc and Twist Bioscience Corp

KYMRKymera Therapeutics Inc

TWSTTwist Bioscience Corp

KYMRKymera Therapeutics Inc

Market cap

$9.25B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

456.91x

Rev growth (TTM)

134.8%

YTD performance

54.5%

52W performance

99.7%

FCF yield

-2.6%

TWSTTwist Bioscience Corp

Market cap

$9.95B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

18.83x

Rev growth (TTM)

19.2%

YTD performance

393.3%

52W performance

387.3%

FCF yield

-1.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KYMR

TWST

Detailed metrics comparison

KYMR

Kymera Therapeutics Inc

TWST

Twist Bioscience Corp

Market Cap

KYMR$9.25B

TWST$9.95B

Enterprise Value

KYMR$9.12B

TWST$9.83B

Price

KYMR$112.40

TWST$159.78

P/E Ratio

KYMRN/A

TWSTN/A

P/S Ratio

KYMR88.06x

TWST23.04x

EV/Sales

KYMR86.90x

TWST22.77x

EV/EBITDA

KYMR0.00x

TWST0.00x

P/B Ratio

KYMR5.92x

TWST27.87x

P/FCF Ratio

KYMRN/A

TWSTN/A

EV/FCF

KYMR-38.34x

TWST-100.10x

PEG Ratio

KYMRN/A

TWSTN/A

Forward P/E (NTM)

KYMRN/A

TWSTN/A

Forward P/S (NTM)

KYMR456.91x

TWST18.83x

Revenue (TTM)

KYMR$105M

TWST$432M

Revenue Growth (YoY)

KYMR134.8%

TWST19.2%

Forward Rev Growth

KYMR-62.1%

TWST15.0%

Gross Margin (TTM)

KYMR0.0%

TWST52.0%

Operating Margin (TTM)

KYMR0.0%

TWST0.0%

EBITDA Margin (TTM)

KYMR-322.0%

TWST-26.0%

Net Margin (TTM)

KYMR-285.3%

TWST-31.7%

FCF Margin (TTM)

KYMR-226.6%

TWST-22.7%

Net Income (TTM)

KYMR$-300M

TWST$-137M

FCF (TTM)

KYMR$-238M

TWST$-98M

EPS (TTM)

KYMR-$3.05

TWST-$2.19

ROE (TTM)

KYMR-2150.0%

TWST-2989.0%

ROA (TTM)

KYMR-1946.0%

TWST-2080.0%

ROIC (TTM)

KYMR-2145.0%

TWST-2989.0%

Cash

KYMR$124M

TWST$117M

Debt

KYMR$2M

TWST$0

Net Cash/Debt

KYMR$122M

TWST$117M

Current Ratio (TTM)

KYMR10.34x

TWST2.67x

Quick Ratio (TTM)

KYMR9.97x

TWST2.30x

Debt/Equity (TTM)

KYMR0.00x

TWST0.00x

Debt/Assets (TTM)

KYMR0.0%

TWST0.0%

Interest Coverage (TTM)

KYMRN/A

TWSTN/A

Net Debt/EBITDA (TTM)

KYMR0.00x

TWST0.00x

Beta

KYMR2.05

TWST2.17

52W Performance

KYMR99.7%

TWST387.3%

YTD Performance

KYMR54.5%

TWST393.3%

% from 52W High

KYMR-13.6%

TWST-27.3%

% from 52W Low

KYMR103.4%

TWST585.8%

Asset Turnover (TTM)

KYMR0.07x

TWST0.66x

FCF Yield (TTM)

KYMR-2.6%

TWST-1.0%

Earnings Yield (TTM)

KYMR-3.2%

TWST-1.4%

Dividend Yield (TTM)

KYMRN/A

TWSTN/A

Rule of 40

KYMR-91.8

TWST-3.6

EV/GP/RG

KYMRN/A

TWST1.94

Ticker research

View KYMR research View TWST research

Metric	KYMR Kymera Therapeutics Inc	TWST Twist Bioscience Corp
Market & Valuation
Market Cap	$9.25B	$9.95B
Enterprise Value	$9.12B	$9.83B
Price	$112.40	$159.78
P/E Ratio	N/A	N/A
P/S Ratio	88.06x	23.04x
EV/Sales	86.90x	22.77x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.92x	27.87x
P/FCF Ratio	N/A	N/A
EV/FCF	-38.34x	-100.10x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	456.91x	18.83x
Revenue & Growth
Revenue (TTM)	$105M	$432M
Revenue Growth (YoY)	134.8%	19.2%
Forward Rev Growth	-62.1%	15.0%
Profitability
Gross Margin (TTM)	0.0%	52.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-322.0%	-26.0%
Net Margin (TTM)	-285.3%	-31.7%
FCF Margin (TTM)	-226.6%	-22.7%
Net Income (TTM)	$-300M	$-137M
FCF (TTM)	$-238M	$-98M
EPS (TTM)	-$3.05	-$2.19
ROE (TTM)	-2150.0%	-2989.0%
ROA (TTM)	-1946.0%	-2080.0%
ROIC (TTM)	-2145.0%	-2989.0%
Financial Health
Cash	$124M	$117M
Debt	$2M	$0
Net Cash/Debt	$122M	$117M
Current Ratio (TTM)	10.34x	2.67x
Quick Ratio (TTM)	9.97x	2.30x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.05	2.17
52W Performance	99.7%	387.3%
YTD Performance	54.5%	393.3%
% from 52W High	-13.6%	-27.3%
% from 52W Low	103.4%	585.8%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.66x
FCF Yield (TTM)	-2.6%	-1.0%
Earnings Yield (TTM)	-3.2%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-91.8	-3.6
EV/GP/RG	N/A	1.94
Ticker research	View KYMR research	View TWST research

Valuation

P/S Ratio

TWST

23.04x

KYMR

88.06x

EV/FCF

TWST

-100.10x

KYMR

-38.34x

Growth & revenue

Revenue Growth TTM

KYMR

134.8%

TWST

19.2%

Forward Revenue Growth

TWST

15.0%

KYMR

-62.1%

Profitability & performance

Gross Margin

TWST

52.0%

KYMR

0.0%

ROE

KYMR

-2150.0%

TWST

-2989.0%

FCF Yield %

TWST

-1.0%

KYMR

-2.6%

52-Week Performance

TWST

387.3%

KYMR

99.7%

Detailed metrics comparison

KYMR

Kymera Therapeutics Inc

TWST

Twist Bioscience Corp

Market Cap

KYMR$9.25B

TWST$9.95B

Enterprise Value

KYMR$9.12B

TWST$9.83B

Price

KYMR$112.40

TWST$159.78

P/E Ratio

KYMRN/A

TWSTN/A

P/S Ratio

KYMR88.06x

TWST23.04x

EV/Sales

KYMR86.90x

TWST22.77x

EV/EBITDA

KYMR0.00x

TWST0.00x

P/B Ratio

KYMR5.92x

TWST27.87x

P/FCF Ratio

KYMRN/A

TWSTN/A

EV/FCF

KYMR-38.34x

TWST-100.10x

PEG Ratio

KYMRN/A

TWSTN/A

Forward P/E (NTM)

KYMRN/A

TWSTN/A

Forward P/S (NTM)

KYMR456.91x

TWST18.83x

Revenue (TTM)

KYMR$105M

TWST$432M

Revenue Growth (YoY)

KYMR134.8%

TWST19.2%

Forward Rev Growth

KYMR-62.1%

TWST15.0%

Gross Margin (TTM)

KYMR0.0%

TWST52.0%

Operating Margin (TTM)

KYMR0.0%

TWST0.0%

EBITDA Margin (TTM)

KYMR-322.0%

TWST-26.0%

Net Margin (TTM)

KYMR-285.3%

TWST-31.7%

FCF Margin (TTM)

KYMR-226.6%

TWST-22.7%

Net Income (TTM)

KYMR$-300M

TWST$-137M

FCF (TTM)

KYMR$-238M

TWST$-98M

EPS (TTM)

KYMR-$3.05

TWST-$2.19

ROE (TTM)

KYMR-2150.0%

TWST-2989.0%

ROA (TTM)

KYMR-1946.0%

TWST-2080.0%

ROIC (TTM)

KYMR-2145.0%

TWST-2989.0%

Cash

KYMR$124M

TWST$117M

Debt

KYMR$2M

TWST$0

Net Cash/Debt

KYMR$122M

TWST$117M

Current Ratio (TTM)

KYMR10.34x

TWST2.67x

Quick Ratio (TTM)

KYMR9.97x

TWST2.30x

Debt/Equity (TTM)

KYMR0.00x

TWST0.00x

Debt/Assets (TTM)

KYMR0.0%

TWST0.0%

Interest Coverage (TTM)

KYMRN/A

TWSTN/A

Net Debt/EBITDA (TTM)

KYMR0.00x

TWST0.00x

Beta

KYMR2.05

TWST2.17

52W Performance

KYMR99.7%

TWST387.3%

YTD Performance

KYMR54.5%

TWST393.3%

% from 52W High

KYMR-13.6%

TWST-27.3%

% from 52W Low

KYMR103.4%

TWST585.8%

Asset Turnover (TTM)

KYMR0.07x

TWST0.66x

FCF Yield (TTM)

KYMR-2.6%

TWST-1.0%

Earnings Yield (TTM)

KYMR-3.2%

TWST-1.4%

Dividend Yield (TTM)

KYMRN/A

TWSTN/A

Rule of 40

KYMR-91.8

TWST-3.6

EV/GP/RG

KYMRN/A

TWST1.94

Ticker research

View KYMR research View TWST research

Metric	KYMR Kymera Therapeutics Inc	TWST Twist Bioscience Corp
Market & Valuation
Market Cap	$9.25B	$9.95B
Enterprise Value	$9.12B	$9.83B
Price	$112.40	$159.78
P/E Ratio	N/A	N/A
P/S Ratio	88.06x	23.04x
EV/Sales	86.90x	22.77x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.92x	27.87x
P/FCF Ratio	N/A	N/A
EV/FCF	-38.34x	-100.10x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	456.91x	18.83x
Revenue & Growth
Revenue (TTM)	$105M	$432M
Revenue Growth (YoY)	134.8%	19.2%
Forward Rev Growth	-62.1%	15.0%
Profitability
Gross Margin (TTM)	0.0%	52.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-322.0%	-26.0%
Net Margin (TTM)	-285.3%	-31.7%
FCF Margin (TTM)	-226.6%	-22.7%
Net Income (TTM)	$-300M	$-137M
FCF (TTM)	$-238M	$-98M
EPS (TTM)	-$3.05	-$2.19
ROE (TTM)	-2150.0%	-2989.0%
ROA (TTM)	-1946.0%	-2080.0%
ROIC (TTM)	-2145.0%	-2989.0%
Financial Health
Cash	$124M	$117M
Debt	$2M	$0
Net Cash/Debt	$122M	$117M
Current Ratio (TTM)	10.34x	2.67x
Quick Ratio (TTM)	9.97x	2.30x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.05	2.17
52W Performance	99.7%	387.3%
YTD Performance	54.5%	393.3%
% from 52W High	-13.6%	-27.3%
% from 52W Low	103.4%	585.8%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.66x
FCF Yield (TTM)	-2.6%	-1.0%
Earnings Yield (TTM)	-3.2%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-91.8	-3.6
EV/GP/RG	N/A	1.94
Ticker research	View KYMR research	View TWST research